ADLAI NORTYE LTD. Share Price Today: Live Updates & Key Insights
ADLAI NORTYE LTD. share price today is $12.04, up -5.45%. The stock opened at $12.64 against the previous close of $13.22, with an intraday high of $12.93 and low of $12.1.
ADLAI NORTYE LTD. Share Price Chart
ADLAI NORTYE LTD.
ADLAI NORTYE LTD. Share Price Performance
ADLAI NORTYE LTD. Institutional Holdings
ADLAI NORTYE LTD. Market Status
ADLAI NORTYE LTD. Fundamentals
Market Cap 851.34 M
PB Ratio 82.7603
PE Ratio 0.0
Enterprise Value 871.27 M
Total Assets 34.43 M
Volume 130695
ADLAI NORTYE LTD. Company Financials
About ADLAI NORTYE LTD. & investment objective
Company Information Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rectal cancer. The company also develops AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers, including pancreatic, lung, and colorectal adenocarcinomas; AN4035, a proprietary CEACAM5-targeting antibody drug conjugate designed to deliver potent anti-tumor activity with an improved therapeutic window; and AN8025, a tri-specific antibody fusion protein which is in phase Ia clinical trial to treat advanced tumors. In addition, it develops AN4005, a small-molecule PD-L1 inhibitor that demonstrates antitumor activity by the blockade of PD-1/PD-L1 interaction which is in phase 1b clinical trial to activate cancer immunity. Further, the company is involved in technology transfer and consulting services business. Adlai Nortye Ltd. was founded in 2004 and is headquartered in North Brunswick, New Jersey.
Organisation Biotechnology
Employees 109
Industry Biotechnology
CEO Mr. Yang Lu EMBA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ADLAI NORTYE LTD. FAQs
What is the share price of ADLAI NORTYE LTD. today?
The current share price of ADLAI NORTYE LTD. is $12.04.
Can I buy ADLAI NORTYE LTD. shares in India?
Yes, Indian investors can buy ADLAI NORTYE LTD. shares by opening an international trading and demat account with Motilal Oswal.
How to buy ADLAI NORTYE LTD. shares in India?
You can easily invest in ADLAI NORTYE LTD. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ADLAI NORTYE LTD. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ADLAI NORTYE LTD..
Can I buy fractional shares of ADLAI NORTYE LTD.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ADLAI NORTYE LTD.?
ADLAI NORTYE LTD. has a market cap of $851.34 M.
In which sector does ADLAI NORTYE LTD. belong?
ADLAI NORTYE LTD. operates in the Biotechnology sector.
What documents are required to invest in ADLAI NORTYE LTD. stocks?
To invest, you typically need:
What is the PE and PB ratio of ADLAI NORTYE LTD.?
The PE ratio of ADLAI NORTYE LTD. is N/A and the PB ratio is 82.76.